XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Aug. 01, 2020
Aug. 03, 2019
Operating activities:    
Net (loss) income $ (270,915,000) $ 105,734,000
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 83,305,000 90,787,000
Share-based compensation 15,654,000 14,298,000
Deferred income taxes (5,437,000) 11,823,000
Loss on impairment of assets [1] 153,617,000  
Changes in assets and liabilities:    
Merchandise inventory 22,119,000 (110,768,000)
Operating lease assets 142,564,000 120,241,000
Operating lease liabilities (70,831,000) (132,279,000)
Other assets (94,433,000) (27,368,000)
Accounts payable 8,591,000 76,326,000
Accrued compensation and payroll taxes 22,797,000 (27,436,000)
Accrued and other liabilities (43,450,000) (3,761,000)
Net cash (used for) provided by operating activities (36,419,000) 117,597,000
Investing activities:    
Capital expenditures for property and equipment (61,402,000) (91,793,000)
Purchase of available-for-sale investments (14,956,000) (50,000,000)
Sale of available-for-sale investments 69,956,000 92,135,000
Other investing activities (372,000) (1,201,000)
Net cash (used for) provided by investing activities (6,774,000) (50,859,000)
Financing activities:    
Repurchase of common stock as part of publicly announced programs (20,000,000) (80,000,000)
Repurchase of common stock from employees (5,215,000) (7,921,000)
Proceeds from revolving line of credit and convertible notes 736,108,000  
Principal payments on revolving line of credit (130,000,000)  
Net proceeds from stock options exercised 0 2,119,000
Cash dividends paid   (46,865,000)
Other financing activities (682,000) (108,000)
Net cash (used for) provided by financing activities 580,211,000 (132,775,000)
Effect of exchange rates changes on cash (161,000) (127,000)
Net change in cash and cash equivalents 536,857,000 (66,164,000)
Cash and cash equivalents - beginning of period 361,930,000 333,330,000
Cash and cash equivalents - end of period $ 898,787,000 $ 267,166,000
[1] There were no impairment charges recorded during the 13 weeks ended August 1, 2020.  During the 26 weeks ended August 1, 2020, the Company recorded impairment charges of $153.6 million.  Of the total, $84.1 million related to the impairment of the operating ROU assets of 272 stores.  We recorded $51.5 million related to the impairment of certain corporate and store property and equipment.  We also recorded $18.0 million of impairment of certain cost and equity method investments.